Sinopep-Allsino Bio Pharmaceutical Co., Ltd.SSE: 688076

Annual Earnings Preannouncement for 2024

Jan 25, 2025 · Issued by Sinopep-Allsino Bio Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 25, 2025

On 6ix: 6ix.com/news/annual-earnings-preannouncement-for-2024-166

Annual Earnings Preannouncement for 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix

Earlier from Sinopep-Allsino Bio Pharmaceutical

Announcement on Using Idle Raised Funds to Temporarily Supplement Current CapitalJan 23, 2025
Announcement on Voluntary Disclosure of Drug GMP Compliance Inspection Passed by Dry Suspension and Granule Production Line in New Oral Solid Preparation WorkshopJan 21, 2025
Announcement on Returning the Raised Funds Temporarily Used for Supplementing Current Capital in AdvanceJan 17, 2025

Later from Sinopep-Allsino Bio Pharmaceutical

Announcement on Voluntary Disclosure of Obtaining the Drug Registration Certificate for Ezetimibe and Atorvastatin Calcium TabletsFeb 10, 2025
Announcement on Voluntary Disclosure of Passing GMP On-site Inspection for DrugsFeb 11, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site InspectionMar 1, 2025
Indicative Announcement on "Sinopep-Allsino Convertible Bonds" Expected to Meet Redemption ConditionsMar 27, 2025

All Sinopep-Allsino Bio Pharmaceutical news releases

Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Sinopep-Allsino Bio Pharmaceutical